Cyclophosphamide Monohydrate 6055-19-2: Pharmaceutical Insights
Discover the critical role of Cyclophosphamide Monohydrate in modern medicine and chemical research.
Get a Quote & SampleProduct Core Value
Cyclophosphamide Monohydrate
Cyclophosphamide Monohydrate (CAS 6055-19-2) is a potent synthetic antineoplastic and immunosuppressive drug. Its core value lies in its ability to alkylate DNA, effectively inhibiting the growth of rapidly proliferating cells, making it crucial for treating various cancers and severe autoimmune conditions.
- Understanding the pharmaceutical applications of cyclophosphamide monohydrate reveals its broad utility in treating severe forms of vasculitis, lupus, and other autoimmune diseases.
- Delve into the cyclophosphamide monohydrate chemical properties, including its appearance as a white to off-white crystalline powder and its high purity (over 99%).
- Explore the cyclophosphamide monohydrate purity and analysis, which involves rigorous testing for identification, water content, and impurities to meet medicine grade standards.
- Learn about the cyclophosphamide monohydrate side effects and administration, noting its use in both oral tablets and intravenous infusions, and the importance of monitoring for infections.
Key Advantages
Broad Therapeutic Spectrum
This compound is vital for its effectiveness in treating a wide range of cancers, including lymphomas, leukemias, and breast carcinoma, as well as serious autoimmune diseases.
High Purity Standards
Ensuring over 99% purity, it meets stringent medicine grade requirements, essential for patient safety and treatment efficacy.
Versatile Administration
The availability in both oral tablet and intravenous infusion forms offers flexibility in patient treatment, catering to different medical needs and preferences.
Key Applications
Cancer Chemotherapy
As a key antineoplastic agent, it is instrumental in chemotherapy regimens for various malignancies, including lymphomas and leukemias.
Autoimmune Disease Management
It serves as a critical immunosuppressive drug for severe manifestations of autoimmune disorders such as lupus and vasculitis.
Pharmaceutical Research and Development
Used as a reference standard and in R&D, it aids in the development and quality control of new pharmaceutical products and therapies.
Nephrotic Syndrome Treatment
In specific pediatric cases, it is employed to induce remission in biopsy-proven minimal change nephrotic syndrome when other treatments are insufficient.